György Várady

2.2k total citations
73 papers, 1.7k citations indexed

About

György Várady is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, György Várady has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 33 papers in Oncology and 10 papers in Physiology. Recurrent topics in György Várady's work include Drug Transport and Resistance Mechanisms (29 papers), RNA Interference and Gene Delivery (11 papers) and CRISPR and Genetic Engineering (9 papers). György Várady is often cited by papers focused on Drug Transport and Resistance Mechanisms (29 papers), RNA Interference and Gene Delivery (11 papers) and CRISPR and Genetic Engineering (9 papers). György Várady collaborates with scholars based in Hungary, United States and Austria. György Várady's co-authors include Balázs Sarkadi, Csilla Özvegy‐Laczka, Katalin Német, András Váradi, Olga Ujhelly, Gÿorgý Kéri, Ágota Apáti, John D. Schuetz, László Homolya and László Őrfi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

György Várady

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
György Várady Hungary 23 989 804 203 156 155 73 1.7k
Elizabeth Hopper-Borge United States 18 954 1.0× 638 0.8× 243 1.2× 168 1.1× 100 0.6× 20 1.5k
Ietje Kathmann Netherlands 23 550 0.6× 649 0.8× 180 0.9× 72 0.5× 139 0.9× 40 1.4k
Eugene Mechetner United States 19 1.0k 1.0× 706 0.9× 227 1.1× 145 0.9× 57 0.4× 39 1.8k
Maria Rius Germany 18 711 0.7× 520 0.6× 257 1.3× 237 1.5× 94 0.6× 22 1.5k
Yu Fukuda United States 18 394 0.4× 601 0.7× 130 0.6× 96 0.6× 100 0.6× 28 1.1k
Orsolya Polgár United States 17 1.5k 1.6× 918 1.1× 464 2.3× 247 1.6× 230 1.5× 18 2.0k
Kieran L. O’Loughlin United States 20 928 0.9× 764 1.0× 230 1.1× 114 0.7× 54 0.3× 33 1.7k
E Schneider United States 17 1.1k 1.1× 1.0k 1.3× 253 1.2× 170 1.1× 107 0.7× 21 1.8k
Kenneth Steadman United States 16 611 0.6× 543 0.7× 174 0.9× 92 0.6× 89 0.6× 28 1.1k
Zi‐Ning Lei United States 29 1.2k 1.2× 1.2k 1.5× 200 1.0× 163 1.0× 85 0.5× 72 2.2k

Countries citing papers authored by György Várady

Since Specialization
Citations

This map shows the geographic impact of György Várady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by György Várady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites György Várady more than expected).

Fields of papers citing papers by György Várady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by György Várady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by György Várady. The network helps show where György Várady may publish in the future.

Co-authorship network of co-authors of György Várady

This figure shows the co-authorship network connecting the top 25 collaborators of György Várady. A scholar is included among the top collaborators of György Várady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with György Várady. György Várady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rácz, Gergely, Éva Oláh, Máté Tóth, et al.. (2025). Identification of new reference genes with stable expression patterns for cell cycle experiments in human leukemia cell lines. Scientific Reports. 15(1). 1052–1052. 1 indexed citations
2.
Szabó, Edit, György Várady, Judit Moldvay, et al.. (2025). Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity. PLoS ONE. 20(1). e0316396–e0316396.
3.
Erdei, Zsuzsa, Edit Szabó, György Várady, et al.. (2024). Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures. International Journal of Molecular Sciences. 25(8). 4515–4515. 1 indexed citations
4.
Lózsa, Rita, Ádám Póti, Eszter Németh, et al.. (2024). Comprehensive investigation of the mutagenic potential of six pesticides classified by IARC as probably carcinogenic to humans. Chemosphere. 362. 142700–142700. 8 indexed citations
5.
Ábrányi‐Balogh, Péter, László Petri, Tı́mea Imre, et al.. (2024). Site-Selective Antibody Conjugation with Dibromopyrazines. Bioconjugate Chemistry. 35(9). 1373–1379. 4 indexed citations
6.
Chiovini, Balázs, Péter Ábrányi‐Balogh, Lúcia Wittner, et al.. (2023). Effective synthesis, development and application of a highly fluorescent cyanine dye for antibody conjugation and microscopy imaging. Organic & Biomolecular Chemistry. 21(44). 8829–8836. 2 indexed citations
7.
Szabó, Beáta, et al.. (2023). KMT2D preferentially binds mRNAs of the genes it regulates, suggesting a role in RNA processing. Protein Science. 33(1). e4847–e4847. 2 indexed citations
8.
Rácz, Gergely, Nikolett Nagy, György Várady, et al.. (2023). Discovery of two new isoforms of the human DUT gene. Scientific Reports. 13(1). 7760–7760. 3 indexed citations
11.
Lehotzky, Attila, Judit Oláh, János Tibor Fekete, et al.. (2021). Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models. Frontiers in Molecular Biosciences. 8. 666026–666026. 14 indexed citations
12.
Iliás, Attila, Péter K. Jani, Zoltán Hegyi, et al.. (2020). Creation of the first monoclonal antibody recognizing an extracellular epitope of hABCC6. FEBS Letters. 595(6). 789–798. 2 indexed citations
13.
Kudlik, Gyöngyi, Kornélia Szebényi, Nóra Kucsma, et al.. (2020). Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line. International Journal of Molecular Sciences. 21(4). 1185–1185. 11 indexed citations
14.
Cserepes, Mihály, Dóra Türk, Szilárd Tóth, et al.. (2019). Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein–Expressing Cells. Cancer Research. 80(4). 663–674. 29 indexed citations
15.
Matula, Zsolt, Anna Szigeti, György Várady, et al.. (2016). In Vitro Characterization of Human Mesenchymal Stem Cells Isolated from Different Tissues with a Potential to Promote Complex Bone Regeneration. Stem Cells International. 2016(1). 3595941–3595941. 33 indexed citations
16.
Szebényi, Kornélia, Zsuzsa Erdei, György Várady, et al.. (2014). Efficient Generation of Human Embryonic Stem Cell-Derived Cardiac Progenitors Based on Tissue-Specific Enhanced Green Fluorescence Protein Expression. Tissue Engineering Part C Methods. 21(1). 35–45. 3 indexed citations
17.
Merkely, Béla, Edit Gara, Wenhua Zhou, et al.. (2014). Signaling Via PI3K/FOXO1A Pathway Modulates Formation and Survival of Human Embryonic Stem Cell-Derived Endothelial Cells. Stem Cells and Development. 24(7). 869–878. 11 indexed citations
18.
Matula, Zsolt, Anna Szigeti, György Várady, et al.. (2014). ABCG2 Is a Selectable Marker for Enhanced Multilineage Differentiation Potential in Periodontal Ligament Stem Cells. Stem Cells and Development. 24(2). 244–252. 8 indexed citations
19.
Apáti, Ágota, Tamás I. Orbán, Nóra Varga, et al.. (2008). High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(12). 2700–2709. 71 indexed citations
20.
Özvegy‐Laczka, Csilla, György Várady, Olga Ujhelly, et al.. (2004). Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface. Journal of Biological Chemistry. 280(6). 4219–4227. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026